SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-20-006859
Filing Date
2020-06-22
Accepted
2020-06-22 09:15:37
Documents
5
Period of Report
2020-06-22
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT cbmg_8k.htm 8-K 29475
2 ADDITIONAL EXHIBITS cbmg_ex991000.htm EX-99.1 1671
3 PRESS RELEASE cbmg_ex992.htm EX-99.2 21529
4 IMAGE cbmg_ex991000000.jpg GRAPHIC 385297
5 IMAGE cbmg_ex992000.jpg GRAPHIC 4766
  Complete submission text file 0001654954-20-006859.txt   591441
Mailing Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105 (347) 905 5663
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36498 | Film No.: 20977339
SIC: 2836 Biological Products, (No Diagnostic Substances)